Hiroko Yamashita

No ORCID on file · 2 papers in corpus

other 2021

Genetic heterogeneity during breast cancer progression in young patients

Breast (Edinburgh, Scotland) ·doi:10.1016/j.breast.2021.10.011

BACKGROUND: Because a number of years may be required for normal cells to develop into carcinoma, genes involved in tumorigenesis and progression might differ among breast cancers in young women and those in older women. The present study s…

rct 2016

A randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-months depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer

Breast cancer (Tokyo, Japan) ·doi:10.1007/s12282-015-0593-z

BACKGROUND: Luteinizing hormone-releasing hormone (LH-RH) agonists provide effective adjuvant treatment for premenopausal women with endocrine-responsive breast cancer. Here, we investigated appropriate treatment durations of an LH-RH agoni…